QQ客服 官方微博 反馈留言

	Apatinib (YN968D1) and Temozolomide in Recurrent Invasive Pituitary Adenoma: Case Report and Literature Review
	Wang, Yong; He, Qiaowei; Meng, Xiangji; Zhou, Shizhen; Zhu, Yufang; Xu, Jun; Tao, Rongjie
刊名	WORLD NEUROSURGERY
	2019
卷号	124页码:319-322
关键词	Antiangiogenic therapy Apatinib Chemotherapy Invasive pituitary adenomas Temozolomide
DOI	10.1016/j.wneu.2018.12.174
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4547858
专题	山东大学
作者单位	Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Dept Neurosur
推荐引用方式 GB/T 7714	Wang, Yong,He, Qiaowei,Meng, Xiangji,et al. Apatinib (YN968D1) and Temozolomide in Recurrent Invasive Pituitary Adenoma: Case Report and Literature Review[J]. WORLD NEUROSURGERY,2019,124:319-322.
APA	Wang, Yong.,He, Qiaowei.,Meng, Xiangji.,Zhou, Shizhen.,Zhu, Yufang.,...&Tao, Rongjie.(2019).Apatinib (YN968D1) and Temozolomide in Recurrent Invasive Pituitary Adenoma: Case Report and Literature Review.WORLD NEUROSURGERY,124,319-322.
MLA	Wang, Yong,et al."Apatinib (YN968D1) and Temozolomide in Recurrent Invasive Pituitary Adenoma: Case Report and Literature Review".WORLD NEUROSURGERY 124(2019):319-322.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。